Partnership gives both groups the exciting opportunity to accelerate development of Satisfai’s innovative suite of AI solutions across the spectrum of Gastroenterology and GI Endoscopy, and to establish Satisfai Health and AIG Hospitals as global leaders in this space.
Vancouver, British Columbia, Canada/ Hyderabad, Telangana, India, October 5, 2020 – Satisfai Health Inc. (the “Company” or “Satisfai Health”), a leading medical company providing artificial intelligence solutions in the field of Gastroenterology, has signed a data licensing and partnership agreement with AIG Hospitals, one of the leading hospitals in India, and the largest centre in Asia for therapeutic endoscopy, to help drive Satisfai’s mission to be the global leader in providing AI solutions in Gastroenterology and GI Endoscopy.
Satisfai Health has already achieved notable success in this domain as a founding member of the ai4gi joint venture, through its license & co-development agreement with Olympus Corporation of the Americas in relation to applying artificial intelligence solutions to help practitioners better diagnose colon polyps during screening for colorectal cancer.
Satisfai Health has continued to extend its reach in terms of developing AI tools in Gastroenterology towards clinical applicability and commercialization using its extensive networks for data procurement, curation, annotation, and advocacy via the global clinical leaders working with Satisfai.
AIG Hospitals is at the forefront of Gastroenterology in India, across Asia, and globally, having been enrolled as a member of the Mayo Clinic Care Network since 2019. The hospital group has been keen to collaborate with a leading medical AI group to harness the power of the huge volume of high quality data now being procured by AIG Hospitals— where up to 500 endoscopic procedures are now completed daily.
“We are now very well established in the rapidly growing field as the leaders of Artificial Intelligence in Gastroenterology, with some critical milestones now achieved for our Company, both academically and commercially”, said Dr Michael Byrne, CEO and founder of Satisfai Health. “A key strategic evolution for Satisfai is the opportunity to partner with truly world renowned groups such as AIG Hospitals. This partnership will dramatically increase our data pipeline and access to very high quality endoscopic and clinical data for our work in AI applications. This Agreement solidifies our collaboration with the clinical innovators and thought-leaders at AIG, including Dr Nageshwar Reddy and Dr Rakesh Kalapala.”
“We are delighted to collaborate with Satisfai Health in the field of AI in Gastroenterology”, said Dr Nageshwar Reddy, chairman of AIG Hospitals. “We are always at the forefront of developing and contributing to innovations in the field of GI Endoscopy, and I am sure AI in GI will take a big leap forward in the near future.”
“I am excited to be a part of this great collaborative work with Satisfai Health”, said Dr Rakesh Kalapala, Director of Endoscopy at AIG. “We at AIG Hospitals thrive constantly for innovation and technology development in GI Endoscopy. I look forward to a productive association and to quickly develop standard algorithms using Artificial Intelligence.”
“AI solutions in gastroenterology are fast becoming a reality” said Dr Doug Rex, a global leader in endoscopy. “Satisfai is the leader at the cutting edge in this space, and this partnership and collaboration with a group I know well—AIG hospitals—can only serve to bring such solutions to our patients sooner. The quality and volume of clinical and endoscopic data generated at AIG is highly impressive”.
“Canada continues to invest heavily in the field of artificial intelligence and machine learning, and recognizes the importance of supporting Canadian companies abroad as they develop new medical technologies,” said Nadir Patel, High Commissioner for Canada to India. “Canada welcomes this new partnership between Satisfai Health Inc. and AIG Hospitals Group in India; a great example of a successful Canadian company advancing and accelerating the development of new AI solutions for early detection and diagnosis of GI cancers, potentially saving lives in Canada, India, and abroad.”
On behalf of the Board of Satisfai Health Inc.
“Dr Michael F. Byrne”
Chairman & CEO
About Satisfai Health Inc.
Satisfai Health Inc. is a leading medical solutions provider specializing in AI applications applied to large addressable markets in gastroenterology. Its solutions deliver real-time analysis of medical imagery and provide clinicians with real-time decision-making intelligence that dramatically improves patient outcomes. Satisfai is supported by a highly respected board of medical clinicians and key opinion leaders who operate at the top of their fields in the many areas of Gastroenterology, and provide us with access to high quality medical data and imaging while also ensuring we focus on the clinical problems with the widest market appeal. We enjoy a strong voice on academic panels and leading GI societies as well as direct access to very large industry players seeking to adopt new AI technologies in Gastroenterology.
Satisfai is a founding member of “ai4gi”, a commercial joint venture with Olympus Corporation of the Americas to develop and commercialize AI solutions for real-time clinical decision support during colonoscopy.
Satisfai Health Contacts:
Dr. Michael Byrne
Chairman & CEO
Phone: +1 604 512 1388
Email: mike@satisfai.health
About AIG Hospitals Group
AIG Hospitals is a unit of Asian Institute of Gastroenterology, India’s foremost Gastroenterology hospital. Spread across 1.4 million sq.ft, AIG Hospitals is a state-of-the-art 800-bed super specialty Hospital, which is among the largest hospitals in the country today.
Led by Dr. D Nageshwar Reddy, Chairman and Managing Director & Dr. G V Rao, Director, AIG Hospitals offers comprehensive healthcare services across 8 key Centres of Excellence – Medical & Surgical Gastroenterology, Liver Sciences, Organ Transplant, Pulmonary Sciences, Renal Sciences, Oncology, Cardiac Sciences, Obesity & Metabolic Therapy.
The Hospital has been custom designed to undertake transplant surgeries including Liver, Kidney, Heart, Pancreas and Islet Cell. All the above services will be well supported by active Emergency and Critical Care services to ensure sick patients get the care they truly deserve.
AIG Hospitals is the first health care facility in India to become a member of the Mayo Clinic Care Network, a group of carefully vetted, independent health care systems that have special access to Mayo Clinic’s knowledge and expertise.
AIG Hospital Contacts:
Dr. Rakesh Kalapala
Phone : +91 9989211034
Email: drrakesh.kalapala@aighospitals.com
aigindia@yahoo.co.in